Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
NCT00044824
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1000
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Fexofenadine
Sponsor
Sanofi